Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

Item
http://www.wikidata.org/entity/Q33747098
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cellsA Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast CancerMaximum a posteriori Bayesian estimation of epirubicin clearance by limited samplingAssessment of the validity of a population pharmacokinetic model for epirubicin.New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.Level of evidence for therapeutic drug monitoring of taxanes.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.
P2860

Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.

Item
http://www.wikidata.org/entity/Q33747098
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
type
label
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
prefLabel
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@ast
Pharmacokinetic optimisation o ...... taxel in patients with cancer.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Pharmacokinetic optimisation o ...... itaxel in patients with cancer
@en
P2093
P2888
P304
P31
P356
10.2165/00003088-199937030-00002
P433
P478
P50
P577
P6179
P698